Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Mack Anthony P. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/07/2023 4/A Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.
Txns: Granted 125,000 options to buy @ $0.867, valued at $108.4k
02/25/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy